TICKERNOMICS Sign up
Last Update: 2024-03-28 02:13:16
Nyxoah SA ( NYXH ) https://www.nyxoah.com
13.37USD
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Country:
Belgium
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
NYXH
80.92%
SPY
32.74%
-37.80%
NYXH
SPY
92.93%
NYXH
0.00%
SPY
224.41%
NYXH
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
422.08
373.16
0.08
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-8.81
105.11
3.68
-15.95
0.00
-8.08
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-1125.61
65.57
-1216.77
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.27
-83.05
-35.78
0.00
Other Earnings and Cash Flow Stats:
Nyxoah SA ( NYXH ) Net Income TTM ($MM) is -40.51
Nyxoah SA ( NYXH ) Operating Income TTM ($MM) is -42.11
Nyxoah SA ( NYXH ) Owners' Earnings Annual ($MM) is 0.00
Nyxoah SA ( NYXH ) Current Price to Owners' Earnings ratio is 0.00
Nyxoah SA ( NYXH ) EBITDA TTM ($MM) is -39.02
Nyxoah SA ( NYXH ) EBITDA Margin is -1216.77%
Capital Allocation:
Nyxoah SA ( NYXH ) has paid 0.00 dividends per share and bought back -2.827706 million shares in the past 12 months
Nyxoah SA ( NYXH ) has reduced its debt by 0.16206866836487 million USD in the last 12 months
Capital Structure:
Nyxoah SA ( NYXH ) Interest-bearing Debt ($MM) as of last quarter is 13
Nyxoah SA ( NYXH ) Annual Working Capital Investments ($MM) are 1
Nyxoah SA ( NYXH ) Book Value ($MM) as of last quarter is 114
Nyxoah SA ( NYXH ) Debt/Capital as of last quarter is 11%
Other Balance Sheet Stats:
Nyxoah SA ( NYXH ) has 14 million in cash on hand as of last quarter
Nyxoah SA ( NYXH ) has 15 million of liabilities due within 12 months, and long term debt 9 as of last quarter
Nyxoah SA ( NYXH ) has 28 common shares outstanding as of last quarter
Nyxoah SA ( NYXH ) has 0 million USD of preferred stock value
Academic Scores:
Nyxoah SA ( NYXH ) Altman Z-Score is 7.11 as of last quarter
Nyxoah SA ( NYXH ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
Nyxoah SA ( NYXH ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of Nyxoah SA ( NYXH ) for the amount of $ on
48.23% of Nyxoah SA ( NYXH ) is held by insiders, and 26.56% is held by institutions
Nyxoah SA ( NYXH ) went public on 2021-07-02
Other Nyxoah SA ( NYXH ) financial metrics:
FCF:-57.15
Unlevered Free Cash Flow:-64.55
EPS:-1.15
Operating Margin:-1125.61
Gross Profit Margin:65.57
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-28.84
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Nyxoah SA ( NYXH ) :
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.